My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Mektix 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg



Krka, d.d., Novo mestoVPA10774/061/002

Main Information

Trade NameMektix 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg
Active SubstancesMilbemycin oxime
Praziquantel
Dosage FormChewable tablet
Licence HolderKrka, d.d., Novo mesto
License Holder AddressŠmarješka cesta 6
8501 Novo mesto
Slovenia
Licence NumberVPA10774/061/002

Group Information

ATC CodeQP54AB51 milbemycin oxime, combinations
Therapeutic ClassEndectoparasiticides
SpeciesDogs

Status

License statusAuthorised
Licence Issued27/07/2018
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back
Follow medicine

Print